Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Eli Lilly And Co (LLY)

2014-11-28@14:11:14 ET
Eli Lilly (LLY) Showing Resistance Near $67.70 (FBM)

2014-11-27@10:58:13 ET
Global Insulin Industry Report 2014 (MTO)

2014-11-26@20:45:52 ET
Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries (EUR)

2014-11-26@13:43:34 ET
Potential Eli Lilly (LLY) Trade Has 1.81% Downside Protection (FBM)

2014-11-26@13:27:13 ET
Eli Lilly (LLY) Breaks Through Resistance at $67.13 (F79)

2014-11-26@12:50:22 ET
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018: Key Vendors are Bristol Myers Squibb, Celgene, Eli Lilly and Co, F. Hoffman La-Roche and GlaxoSmithKline (EUR)

2014-11-25@12:40:10 ET
Global Product and Pipeline Analysis of the Rheumatoid Arthritis Therapeutics Market 2014-2016 (MTO)

2014-11-25@11:25:06 ET
Potential Eli Lilly (LLY) Trade Has 1.87% Downside Protection (FBM)

2014-11-25@08:20:45 ET
Short-term Underperformance Detected in Shares of Valeant Pharmaceuticals International in the Pharmaceuticals Industry (VRX, JNJ, PFE, MRK, LLY) (F70)

2014-11-25@06:01:42 ET
Global PCSK9 and Other Novel Hypercholesterolemia Drugs Market: 10 Year Forecasts (MTO)

2014-11-24@15:54:37 ET
Potential Eli Lilly (LLY) Trade Has 2.23% Downside Protection (FBM)

2014-11-24@03:58:55 ET
Deal snapshot: EC TO UNVEIL STAND ON ELI LILLY, NOVARTIS DEAL BY 3 OCT (MTN)

2014-11-21@13:26:13 ET
Eli Lilly (LLY) Showing Support Near $66.29 (FBM)

2014-11-21@07:12:12 ET
Merrimack Pharmaceuticals' MM-398 Gets Fast Track Status (ZAX)

2014-11-20@10:51:53 ET
Eli Lilly (LLY) Showing Bullish Technicals (FBM)

2014-11-20@10:39:05 ET
Eli Lilly (LLY) Crosses Pivot Point Support at $66.86 (F79)

2014-11-19@09:30:00 ET
National Alliance for Hispanic Health Survey Provides Insights into Hispanic Attitudes Towards Diabetes (PRN)

2014-11-19@07:10:09 ET
Pharma Industry Outlook: M&A, Licensing Abound (ZAX)

2014-11-19@07:10:05 ET
Pharma Industry Outlook: M&A, Licensing Abound (ZAX)

2014-11-19@05:24:10 ET
Eli Lilly announces availability of type 2 diabetes drug in US (DTM)